The day's most important news and information in brief.

A Fourth Estate® Service.

Sunday, September 19, 2021

Johnson & Johnson Resumes COVID-19 Vaccine Trials in Brazil

Brazilian health regulator Anvisa announced in a Wednesday statement that it formally authorized the resumption of a clinical trial of Johnson & Johnson’s experimental COVID-19 vaccine.

Brazilian health regulator Anvisa announced in a Wednesday statement that it formally authorized the resumption of a clinical trial of Johnson & Johnson’s experimental COVID-19 vaccine.

Anvisa approved the resume of the clinical trial following a reunion between health authorities and President Jjair Bolsonaro in which the Brazilian government decided that “it was crucial to release a reliable vaccine as soon as possible.”

The Johnson & Johnson vaccine is one of four being tested in Brazil, which has the world’s third-worst outbreak behind the United States and India, and the second-highest virus death toll.

Johnson & Johnson’s trial in the country had been suspended since October 12th, so a safety panel could evaluate an unexplained illness of a participant in its planned 60,000-person Phase III study. Testing of the vaccine in the United States resumed in October’s first week.

The Brazilian health regulator said when the trial was interrupted, 12 volunteers in Brazil, all from the state of Rio de Janeiro, had either received a dose of the vaccine or a placebo.

Article © 2021 Fourth Estate® — All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Recent Articles

spot_img

Get the Daily NewsBrief in your inbox

Related Stories